8-K · 2026-11-10
Acrivon Therapeutics held a webcast discussing new immunology programs, showcasing its AI-driven AP3 platform and addressing Eosinophilic esophagitis.
| Name | Acrivon Therapeutics, Inc. |
|---|---|
| CIK | 0001781174 |
| Tickers | ACRV |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 825125532 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 617-207-8979 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Acrivon Therapeutics held a webcast discussing new immunology programs, showcasing its AI-driven AP3 platform and addressing Eosinophilic esophagitis.
Acrivon Therapeutics has entered into an asset purchase agreement with Aqilion AB, acquiring programs for oral JAK1 inhibitors and PKCθ inhibitors.
359 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-470245 | 001-41551 | 261579243 | 34 | 7669624 | 1 | 1 |
| 2026-11-19 | 4 | FORM 4 | 0000905148-26-005056 | 5146 | ||||||
| 2026-11-19 | 4 | FORM 4 | 0000905148-26-005055 | 5159 | ||||||
| 2026-11-19 | 4 | FORM 4 | 0000905148-26-005053 | 5169 | ||||||
| 2026-11-19 | 4 | FORM 4 | 0000905148-26-005051 | 5205 | ||||||
| 2026-11-19 | 4 | FORM 4 | 0000905148-26-005050 | 9006 | ||||||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-005014 | 001-41551 | 261567662 | 33 | 7467 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-005013 | 001-41551 | 261567659 | 33 | 7493 | |||
| 2026-11-16 | S-3 | S-3 | 0001193125-26-463828 | 333-300095 | 261562762 | 33 | 850727 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-463444 | 001-41551 | 261560474 | 34 | 464668 | 1 | 1 |
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-463419 | 001-41551 | 261560349 | 34 | 8334819 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-455669 | 001-41551 | 261541307 | 34 | 13901065 | 1 | 1 |
| 2026-11-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-450779 | 001-41551 | 261529411 | 34 | 278182 | 1 | 1 |
| 2026-10-26 | 4 | FORM 4 | 0000905148-26-004554 | 4993 | ||||||
| 2026-10-07 | 4 | FORM 4 | 0000905148-26-004399 | 5155 | ||||||
| 2026-09-02 | 4 | FORM 4 | 0000905148-26-004065 | 7248 | ||||||
| 2026-09-02 | 3 | FORM 3 | 0000905148-26-004064 | 14671 | ||||||
| 2026-08-27 | 4 | FORM 4 | 0000905148-26-003968 | 8236 | ||||||
| 2026-08-25 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-003924 | 001-41551 | 261317355 | 33 | 6796 | |||
| 2026-08-20 | 4 | FORM 4 | 0000905148-26-003840 | 4699 | ||||||
| 2026-08-20 | 4 | FORM 4 | 0000905148-26-003839 | 4712 | ||||||
| 2026-08-20 | 4 | FORM 4 | 0000905148-26-003838 | 4722 | ||||||
| 2026-08-20 | 4 | FORM 4 | 0000905148-26-003837 | 4717 | ||||||
| 2026-08-20 | 4 | FORM 4 | 0000905148-26-003836 | 8515 | ||||||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001875620-26-000015 | 005-93824 | 261271274 | 34 | 17355 | |||
| 2026-08-12 | S-8 | S-8 | 0001193125-26-347003 | 333-298271 | 261268190 | 33 | 189039 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-346859 | 001-41551 | 261267566 | 34 | 435755 | 1 | 1 |
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346819 | 001-41551 | 261267452 | 34 | 8074818 | 1 | 1 | |
| 2026-08-06 | 4 | FORM 4 | 0000905148-26-003499 | 4669 | ||||||
| 2026-07-23 | 4 | FORM 4 | 0000905148-26-003334 | 4712 | ||||||
| 2026-06-22 | 4 | xslF345X06/form4-06222026_080632.xml | 0001231919-26-000686 | 14153 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0000905148-26-003042 | 5330 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0000905148-26-003041 | 5411 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0000905148-26-003035 | 5373 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0000905148-26-003034 | 5574 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0000905148-26-003033 | 6038 | ||||||
| 2026-06-22 | 4 | FORM 4 | 0000905148-26-003024 | 5422 | ||||||
| 2026-06-17 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-274410 | 001-41551 | 261099550 | 34 | 583104 | 1 | 1 |
| 2026-05-26 | 4 | FORM 4 | 0000905148-26-002652 | 7685 | ||||||
| 2026-05-22 | DEFA14A | DEFA14A | 0001193125-26-236858 | 001-41551 | 261013634 | 34 | 4858294 | 1 | 1 | |
| 2026-05-20 | 4 | xslF345X06/form4-05202026_080548.xml | 0001231919-26-000517 | 15298 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002563 | 4777 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002562 | 4858 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002560 | 4820 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002559 | 5021 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002558 | 5451 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002557 | 4822 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002556 | 4995 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002555 | 5028 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002553 | 5008 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002552 | 4982 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002551 | 5018 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002550 | 5013 | ||||||
| 2026-05-20 | 4 | FORM 4 | 0000905148-26-002549 | 8810 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0000905148-26-002502 | 4700 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0000905148-26-002501 | 4715 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0000905148-26-002500 | 4725 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0000905148-26-002499 | 4719 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0000905148-26-002498 | 8517 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062728 | 005-93824 | 26989135 | 34 | 17994 | |||
| 2026-05-13 | 10-Q | 10-Q | 0001193125-26-221634 | 001-41551 | 26973386 | 34 | 7200371 | 1 | 1 | |
| 2026-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-221626 | 001-41551 | 26973338 | 34 | 389544 | 1 | 1 |
| 2026-04-30 | ARS | ARS | 0001193125-26-194214 | 001-41551 | 26920318 | 34 | 1830119 | |||
| 2026-04-30 | DEFA14A | DEFA14A | 0001193125-26-194211 | 001-41551 | 26920311 | 34 | 3501317 | 1 | 1 | |
| 2026-04-30 | DEF 14A | DEF 14A | 0001193125-26-194206 | 001-41551 | 26920294 | 34 | 5325472 | 1 | 1 | |
| 2026-04-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001346824-26-000116 | 005-93824 | 26889064 | 34 | 15783 | |||
| 2026-04-23 | 4 | xslF345X06/form4-04232026_080403.xml | 0001231919-26-000396 | 13625 | ||||||
| 2026-04-21 | 4 | FORM 4 | 0000905148-26-001768 | 4715 | ||||||
| 2026-03-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001346824-26-000081 | 005-93824 | 26782604 | 34 | 15443 | |||
| 2026-03-19 | S-8 | S-8 | 0001193125-26-115150 | 333-294425 | 26772425 | 33 | 190951 | 1 | 1 | |
| 2026-03-19 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-115139 | 001-41551 | 26772402 | 34 | 26005148 | 1 | 1 |
| 2026-03-19 | 10-K | 10-K | 0001193125-26-115123 | 001-41551 | 26772384 | 34 | 12398081 | 1 | 1 | |
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001121 | 5334 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001120 | 5370 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001119 | 5397 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001118 | 5306 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001117 | 5357 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001116 | 5354 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0000905148-26-001115 | 9689 | ||||||
| 2026-03-02 | 8-K | 8-K | 1.02 | 0001193125-26-085516 | 001-41551 | 26708237 | 34 | 142207 | 1 | 1 |
| 2026-02-27 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-079500 | 001-41551 | 26693005 | 34 | 2002127 | 1 | 1 |
| 2026-02-24 | 4 | FORM 4 | 0000905148-26-001010 | 7475 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0000905148-26-000939 | 4564 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0000905148-26-000937 | 4578 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0000905148-26-000936 | 4588 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0000905148-26-000935 | 4582 | ||||||
| 2026-02-18 | 4 | FORM 4 | 0000905148-26-000934 | 8309 | ||||||
| 2026-01-21 | 4 | xslF345X05/form4.xml | 0000905148-26-000281 | 4417 | ||||||
| 2026-01-16 | 4 | xslF345X05/form4.xml | 0000905148-26-000226 | 7628 | ||||||
| 2026-01-16 | 4 | xslF345X05/form4.xml | 0000905148-26-000225 | 4743 | ||||||
| 2026-01-15 | 4 | xslF345X05/form4.xml | 0000905148-26-000212 | 4792 | ||||||
| 2026-01-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-007077 | 001-41551 | 26517609 | 34 | 17491516 | 1 | 1 |
| 2026-01-08 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-26-007007 | 001-41551 | 26517396 | 34 | 331988 | 1 | 1 |
| 2025-11-25 | 4 | xslF345X05/form4.xml | 0000905148-25-004179 | 7264 | ||||||
| 2025-11-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-115063 | 005-93824 | 251509140 | 34 | 29242 | |||
| 2025-11-18 | 4 | xslF345X05/form4.xml | 0000905148-25-004131 | 4403 | ||||||
| 2025-11-18 | 4 | xslF345X05/form4.xml | 0000905148-25-004130 | 4418 | ||||||
| 2025-11-18 | 4 | xslF345X05/form4.xml | 0000905148-25-004129 | 4428 | ||||||
| 2025-11-18 | 4 | xslF345X05/form4.xml | 0000905148-25-004128 | 4422 | ||||||
| 2025-11-18 | 4 | xslF345X05/form4.xml | 0000905148-25-004127 | 8096 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112501 | 005-93824 | 251485964 | 34 | 18214 | |||
| 2025-11-13 | 10-Q | 10-Q | 0001193125-25-280215 | 001-41551 | 251478762 | 34 | 8292576 | 1 | 1 | |
| 2025-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-280172 | 001-41551 | 251478533 | 34 | 436069 | 1 | 1 |
| 2025-10-21 | 4 | xslF345X05/form4.xml | 0000905148-25-003637 | 4418 | ||||||
| 2025-10-03 | 4 | xslF345X05/form4.xml | 0000905148-25-003507 | 5213 | ||||||
| 2025-10-03 | 4 | xslF345X05/form4.xml | 0000905148-25-003506 | 4418 | ||||||
| 2025-09-05 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-197250 | 001-41551 | 251297055 | 34 | 33782534 | 1 | 1 |
| 2025-08-25 | 4 | xslF345X05/form4.xml | 0000905148-25-003121 | 7275 | ||||||
| 2025-08-18 | 4 | xslF345X05/form4.xml | 0000905148-25-003043 | 16314 | ||||||
| 2025-08-18 | 4 | xslF345X05/form4.xml | 0000905148-25-003042 | 4418 | ||||||
| 2025-08-18 | 4 | xslF345X05/form4.xml | 0000905148-25-003041 | 16356 | ||||||
| 2025-08-18 | 4 | xslF345X05/form4.xml | 0000905148-25-003040 | 16332 | ||||||
| 2025-08-18 | 4 | xslF345X05/form4.xml | 0000905148-25-003039 | 8096 | ||||||
| 2025-08-13 | 10-Q | 10-Q | 0000950170-25-108054 | 001-41551 | 251211890 | 34 | 8612063 | 1 | 1 | |
| 2025-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-179834 | 001-41551 | 251211828 | 34 | 436336 | 1 | 1 |
| 2025-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001875620-25-000020 | 005-93824 | 251209628 | 34 | 17238 | |||
| 2025-08-05 | 4 | xslF345X05/form4.xml | 0000905148-25-002732 | 4375 | ||||||
| 2025-07-21 | 4 | xslF345X05/form4.xml | 0000905148-25-002493 | 4412 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4-06182025_120627.xml | 0001415889-25-017627 | 13821 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0000905148-25-002177 | 17583 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0000905148-25-002174 | 16897 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0000905148-25-002173 | 17031 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0000905148-25-002172 | 16774 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0000905148-25-002171 | 17151 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0000905148-25-002170 | 16769 | ||||||
| 2025-06-13 | 8-K | 8-K | 5.07 | 0000950170-25-086246 | 001-41551 | 251047016 | 34 | 174381 | 1 | 1 |
| 2025-06-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-081605 | 005-93824 | 251023093 | 34 | 10284 | |||
| 2025-05-23 | 4 | xslF345X05/form4.xml | 0000905148-25-001900 | 31367 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4.xml | 0000905148-25-001824 | 4401 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4.xml | 0000905148-25-001823 | 4410 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4.xml | 0000905148-25-001822 | 4426 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4.xml | 0000905148-25-001821 | 4402 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4.xml | 0000905148-25-001820 | 8092 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-049618 | 005-93824 | 25955926 | 34 | 18413 | |||
| 2025-05-14 | S-8 | S-8 | 0001193125-25-119914 | 333-287277 | 25946645 | 33 | 79173 | |||
| 2025-05-14 | 10-Q | 10-Q | 0000950170-25-071427 | 001-41551 | 25945769 | 34 | 8321281 | 1 | 1 | |
| 2025-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-071385 | 001-41551 | 25945536 | 34 | 397003 | 1 | 1 |
| 2025-05-01 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-062201 | 005-93824 | 25905142 | 34 | 10557 | |||
| 2025-05-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-008341 | 11166 | ||||||
| 2025-04-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-008214 | 13090 | ||||||
| 2025-04-25 | ARS | ARS | 0000950170-25-058357 | 001-41551 | 25870128 | 34 | 21259900 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0000950170-25-058356 | 001-41551 | 25870123 | 34 | 3724363 | 1 | 1 | |
| 2025-04-25 | DEF 14A | DEF 14A | 0000950170-25-058352 | 001-41551 | 25870114 | 34 | 5381248 | 1 | 1 | |
| 2025-04-21 | 3 | xslF345X02/form3.xml | 0000905148-25-001264 | 15281 | ||||||
| 2025-04-18 | 4 | xslF345X05/form4.xml | 0000905148-25-001257 | 4411 | ||||||
| 2025-04-07 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-051576 | 001-41551 | 25818132 | 34 | 272003 | 1 | 1 |
| 2025-04-03 | 4 | xslF345X05/form4.xml | 0000905148-25-001076 | 16939 | ||||||
| 2025-04-03 | 4 | xslF345X05/form4.xml | 0000905148-25-001075 | 5142 | ||||||
| 2025-04-03 | 3 | xslF345X02/form3.xml | 0000905148-25-001074 | 19719 | ||||||
| 2025-03-28 | S-8 | S-8 | 0001193125-25-066369 | 333-286208 | 25781776 | 33 | 73388 | |||
| 2025-03-27 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-046163 | 001-41551 | 25780127 | 34 | 443253 | 1 | 1 |
| 2025-03-27 | 10-K | 10-K | 0000950170-25-046056 | 001-41551 | 25779305 | 34 | 100633020 | 1 | 1 | |
| 2025-03-25 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-25-044549 | 001-41551 | 25769295 | 34 | 25633484 | 1 | 1 |
| 2025-03-14 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-039520 | 001-41551 | 25740904 | 34 | 253205 | 1 | 1 |
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000842 | 5189 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000840 | 5196 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000838 | 5211 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000836 | 5212 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000834 | 5209 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000831 | 5218 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4.xml | 0000905148-25-000828 | 9498 | ||||||
| 2025-02-25 | 4 | xslF345X05/form4.xml | 0000905148-25-000764 | 7288 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000905148-25-000730 | 4419 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000905148-25-000729 | 4427 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000905148-25-000728 | 4439 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000905148-25-000727 | 4443 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000905148-25-000726 | 4437 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000905148-25-000725 | 8119 | ||||||
| 2025-01-22 | 4 | xslF345X05/form4.xml | 0000905148-25-000168 | 4427 | ||||||
| 2024-11-27 | 4 | xslF345X05/form4.xml | 0000905148-24-003295 | 5196 | ||||||
| 2024-11-27 | 4 | xslF345X05/form4.xml | 0000905148-24-003293 | 5208 | ||||||
| 2024-11-27 | 4 | xslF345X05/form4.xml | 0000905148-24-003291 | 5212 | ||||||
| 2024-11-27 | 4 | xslF345X05/form4.xml | 0000905148-24-003289 | 5206 | ||||||
| 2024-11-27 | 4 | xslF345X05/form4.xml | 0000905148-24-003287 | 9495 | ||||||
| 2024-11-25 | 4 | xslF345X05/form4.xml | 0000905148-24-003270 | 7290 | ||||||
| 2024-11-18 | 4 | xslF345X05/form4.xml | 0000905148-24-003228 | 4419 | ||||||
| 2024-11-18 | 4 | xslF345X05/form4.xml | 0000905148-24-003227 | 4428 | ||||||
| 2024-11-18 | 4 | xslF345X05/form4.xml | 0000905148-24-003226 | 4440 | ||||||
| 2024-11-18 | 4 | xslF345X05/form4.xml | 0000905148-24-003225 | 4444 | ||||||
| 2024-11-18 | 4 | xslF345X05/form4.xml | 0000905148-24-003224 | 4438 | ||||||
| 2024-11-18 | 4 | xslF345X05/form4.xml | 0000905148-24-003223 | 8121 | ||||||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-125929 | 001-41551 | 241451145 | 34 | 7786065 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-125920 | 001-41551 | 241451110 | 34 | 351565 | 1 | 1 |
| 2024-10-21 | 4 | xslF345X05/form4.xml | 0000905148-24-002773 | 4428 | ||||||
| 2024-10-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-114213 | 001-41551 | 241366430 | 34 | 206371 | 1 | 1 |
| 2024-10-03 | 4 | xslF345X05/form4.xml | 0000905148-24-002637 | 4428 | ||||||
| 2024-09-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-219180 | 001-41551 | 241299285 | 34 | 6711153 | 1 | 1 |
| 2024-08-23 | 4 | xslF345X05/form4.xml | 0000905148-24-002335 | 7291 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002283 | 4419 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002282 | 4428 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002281 | 5479 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002280 | 4440 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002279 | 4444 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002278 | 4438 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4.xml | 0000905148-24-002277 | 5489 | ||||||
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095766 | 001-41551 | 241198834 | 34 | 329669 | 1 | 1 |
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-095760 | 001-41551 | 241198793 | 34 | 7508606 | 1 | 1 | |
| 2024-07-19 | 4 | FORM 4 | 0001140361-24-033600 | 4448 | ||||||
| 2024-07-10 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-060604 | 005-93824 | 241110900 | 34 | 92937 | |||
| 2024-07-10 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-060601 | 005-93824 | 241110894 | 34 | 123287 | |||
| 2024-06-24 | 4 | xslF345X05/form4-06242024_090612.xml | 0001415889-24-018035 | 13829 | ||||||
| 2024-06-24 | 4 | xslF345X05/form4.xml | 0000905148-24-001777 | 16161 | ||||||
| 2024-06-24 | 4 | xslF345X05/form4.xml | 0000905148-24-001776 | 5094 | ||||||
| 2024-06-24 | 4 | xslF345X05/form4.xml | 0000905148-24-001775 | 16847 | ||||||
| 2024-06-24 | 4 | xslF345X05/form4.xml | 0000905148-24-001774 | 5096 | ||||||
| 2024-06-21 | 8-K | 8-K | 5.07 | 0000950170-24-075760 | 001-41551 | 241057621 | 34 | 172595 | 1 | 1 |
| 2024-05-21 | 4 | xslF345X05/form4.xml | 0000905148-24-001566 | 6634 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001495 | 4418 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001493 | 4427 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001491 | 5478 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001489 | 4439 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001487 | 4443 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001485 | 4437 | ||||||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0000905148-24-001483 | 5488 | ||||||
| 2024-05-16 | 3 | xslF345X02/form3.xml | 0000905148-24-001481 | 18835 | ||||||
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-059097 | 001-41551 | 24941498 | 34 | 290441 | 1 | 1 |
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059084 | 001-41551 | 24941467 | 34 | 6436748 | 1 | 1 | |
| 2024-04-29 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-29 09:00:00 | 9999999995-24-001188 | 333-278761 | 24893781 | 33 | 1705 | ||
| 2024-04-26 | ARS | ARS | 0000950170-24-048675 | 001-41551 | 24879029 | 34 | 16866847 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-048673 | 001-41551 | 24879013 | 34 | 2547043 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-048671 | 001-41551 | 24878978 | 34 | 3264222 | |||
| 2024-04-24 | CORRESP | filename1.htm | 0001193125-24-110404 | 6269 | ||||||
| 2024-04-24 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-24-047560 | 001-41551 | 24870490 | 34 | 23881818 | 1 | 1 |
| 2024-04-19 | 4 | xslF345X05/form4.xml | 0000905148-24-001186 | 4428 | ||||||
| 2024-04-19 | UPLOAD | filename1.pdf | 0000000000-24-004299 | 333-278761 | 40330 | |||||
| 2024-04-17 | S-3 | S-3 | 0001193125-24-099152 | 333-278761 | 24851612 | 33 | 319998 | |||
| 2024-04-15 | 4 | xslF345X05/form4-04152024_040401.xml | 0001415889-24-010809 | 13210 | ||||||
| 2024-04-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-008378 | 8657 | ||||||
| 2024-04-15 | SC 13G/A | SC 13G/A | 0001193125-24-095564 | 005-93824 | 24843186 | 34 | 63916 | |||
| 2024-04-11 | SC 13D/A | SC 13D/A | 0001104659-24-046306 | 005-93824 | 24838716 | 34 | 93947 | |||
| 2024-04-09 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0000950170-24-042789 | 001-41551 | 24831097 | 34 | 1292164 | 1 | 1 |
| 2024-03-29 | S-8 | S-8 | 0001193125-24-081596 | 333-278365 | 24802222 | 33 | 77903 | |||
| 2024-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-037627 | 001-41551 | 24793594 | 34 | 327494 | 1 | 1 |
| 2024-03-28 | 10-K | 10-K | 0000950170-24-037618 | 001-41551 | 24793537 | 34 | 94467748 | 1 | 1 | |
| 2024-03-06 | 4 | xslF345X05/form4.xml | 0000905148-24-000904 | 5216 | ||||||
| 2024-03-06 | 3 | xslF345X02/form3.xml | 0000905148-24-000901 | 14295 | ||||||
| 2024-03-04 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-056937 | 001-41551 | 24712918 | 34 | 177996 | 1 | 1 |
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000765 | 4426 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000764 | 5477 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000763 | 4438 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000762 | 4442 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000761 | 4436 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000760 | 5487 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023918 | 005-93824 | 24639948 | 34 | 136606 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036370 | 005-93824 | 24639367 | 34 | 64609 | |||
| 2024-02-14 | SC 13G/A | ACRIVON THERAPEUTICS, INC. | 0000902664-24-001626 | 005-93824 | 24633314 | 34 | 52019 | |||
| 2024-02-13 | SC 13G/A | acrv_13ga.htm | 0000908834-24-000055 | 005-93824 | 24625332 | 34 | 66488 | |||
| 2024-02-09 | 4 | xslF345X05/form4.xml | 0000905148-24-000533 | 5401 | ||||||
| 2024-02-09 | 3 | xslF345X02/form3.xml | 0000905148-24-000531 | 14342 | ||||||
| 2024-02-08 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-027629 | 001-41551 | 24606960 | 34 | 178409 | 1 | 1 |
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0000905148-24-000240 | 4427 | ||||||
| 2024-01-16 | 4 | xslF345X05/form4.xml | 0000905148-24-000183 | 5238 | ||||||
| 2024-01-12 | 3 | xslF345X02/form3.xml | 0000905148-24-000165 | 14290 | ||||||
| 2024-01-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-003885 | 001-41551 | 24518335 | 34 | 6760172 | 1 | 1 |
| 2023-12-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-12-15 16:30:00 | 9999999995-23-003657 | 333-275854 | 231492128 | 33 | 1706 | ||
| 2023-12-12 | CORRESP | filename1.htm | 0001193125-23-293526 | 7994 | ||||||
| 2023-12-08 | 8-K | 8-K | 1.01 | 0001193125-23-291705 | 001-41551 | 231475683 | 34 | 147175 | 1 | 1 |
| 2023-12-05 | UPLOAD | filename1.pdf | 0000000000-23-013218 | 40246 | ||||||
| 2023-12-01 | S-3 | S-3 | 0001193125-23-287501 | 333-275854 | 231460058 | 33 | 1170789 | |||
| 2023-11-16 | 4 | xslF345X05/form4.xml | 0000905148-23-001477 | 4346 | ||||||
| 2023-11-16 | 4 | xslF345X05/form4.xml | 0000905148-23-001476 | 17516 | ||||||
| 2023-11-16 | 4 | xslF345X05/form4.xml | 0000905148-23-001475 | 4359 | ||||||
| 2023-11-16 | 4 | xslF345X05/form4.xml | 0000905148-23-001474 | 4359 | ||||||
| 2023-11-16 | 4 | xslF345X05/form4.xml | 0000905148-23-001473 | 4357 | ||||||
| 2023-11-16 | 4 | xslF345X05/form4.xml | 0000905148-23-001472 | 5408 | ||||||
| 2023-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-23-274124 | 001-41551 | 231390316 | 34 | 19683457 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-061553 | 001-41551 | 231390149 | 34 | 9489691 | 1 | 1 | |
| 2023-10-19 | 4 | xslF345X05/form4.xml | 0000905148-23-001156 | 4347 | ||||||
| 2023-09-28 | 4 | xslF345X05/form4.xml | 0000905148-23-001029 | 7041 | ||||||
| 2023-09-28 | 3 | xslF345X02/form3.xml | 0000905148-23-001028 | 18952 | ||||||
| 2023-09-05 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-228639 | 001-41551 | 231236984 | 34 | 18757571 | 1 | 1 |
| 2023-08-23 | 4 | xslF345X05/form4.xml | 0000905148-23-000783 | 5699 | ||||||
| 2023-08-11 | S-8 | S-8 | 0001193125-23-209859 | 333-273908 | 231161645 | 33 | 80205 | |||
| 2023-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-209745 | 001-41551 | 231161504 | 34 | 234091 | 1 | 1 |
| 2023-08-11 | 10-Q | 10-Q | 0000950170-23-041593 | 001-41551 | 231161493 | 34 | 9789976 | 1 | 1 | |
| 2023-06-28 | 4 | xslF345X04/form4.xml | 0001140361-23-031959 | 5138 | ||||||
| 2023-06-28 | 3 | xslF345X02/form3.xml | 0001140361-23-031954 | 15421 | ||||||
| 2023-06-28 | 4 | xslF345X04/ownership.xml | 0001213900-23-052442 | 13967 | ||||||
| 2023-06-22 | 8-K | 8-K | 5.07 | 0000950170-23-029447 | 001-41551 | 231034067 | 34 | 233313 | 1 | 1 |
| 2023-06-20 | 4 | xslF345X04/form4.xml | 0001140361-23-030544 | 16966 | ||||||
| 2023-06-20 | 4 | xslF345X04/ownership.xml | 0001213900-23-050160 | 13998 | ||||||
| 2023-06-14 | 4 | xslF345X04/ownership.xml | 0001213900-23-049014 | 17635 | ||||||
| 2023-06-12 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000245 | 001-41551 | 231007516 | 33 | 4610 | |||
| 2023-06-06 | 4 | xslF345X04/form4.xml | 0001140361-23-028539 | 17126 | ||||||
| 2023-06-05 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-160789 | 001-41551 | 23993555 | 34 | 310414 | 1 | 1 |
| 2023-06-01 | 4 | xslF345X04/form4.xml | 0001140361-23-027860 | 20060 | ||||||
| 2023-05-30 | DEFR14A | DEFR14A | 0001193125-23-156608 | 001-41551 | 23976765 | 34 | 433948 | |||
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-138948 | 001-41551 | 23900084 | 34 | 255186 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019157 | 001-41551 | 23900066 | 34 | 9157880 | 1 | 1 | |
| 2023-05-01 | ARS | ARS | 0000950170-23-016275 | 001-41551 | 23874153 | 34 | 3691709 | |||
| 2023-05-01 | DEFA14A | DEFA14A | 0000950170-23-016272 | 001-41551 | 23874077 | 34 | 1104435 | |||
| 2023-05-01 | DEF 14A | DEF 14A | 0000950170-23-016268 | 001-41551 | 23874029 | 34 | 3916150 | |||
| 2023-05-01 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-129712 | 001-41551 | 23871896 | 34 | 12753215 | 1 | 1 |
| 2023-05-01 | 8-K | 8-K | 2.02 | 0001193125-23-128896 | 001-41551 | 23870365 | 34 | 147711 | 1 | 1 |
| 2023-04-25 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-114750 | 001-41551 | 23843069 | 34 | 15186748 | 1 | 1 |
| 2023-03-30 | SC 13D/A | SC 13D/A | 0001104659-23-039254 | 005-93824 | 23781616 | 34 | 91537 | |||
| 2023-03-29 | S-8 | S-8 | 0001193125-23-082963 | 333-270923 | 23771840 | 33 | 73804 | |||
| 2023-03-28 | 10-K | 10-K | 0000950170-23-010331 | 001-41551 | 23770204 | 34 | 111349450 | 1 | 1 | |
| 2023-03-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-081445 | 001-41551 | 23766257 | 34 | 237159 | 1 | 1 |
| 2023-03-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-23-068545 | 001-41551 | 23725880 | 34 | 15088151 | 1 | 1 |
| 2023-03-03 | 8-K | 8-K | 8.01 | 0001193125-23-060173 | 001-41551 | 23705558 | 34 | 150125 | 1 | 1 |
| 2023-02-14 | SC 13G/A | 13ga1_acrivon.htm | 0001175707-23-000086 | 005-93824 | 23627901 | 34 | 100556 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-038734 | 005-93824 | 23627265 | 34 | 65405 | |||
| 2023-02-14 | SC 13G | ACRIVON THERAPEUTICS, INC. | 0000902664-23-001677 | 005-93824 | 23623492 | 34 | 50222 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020729 | 005-93824 | 23622661 | 34 | 137887 | |||
| 2022-12-15 | 10-Q | 10-Q | 0000950170-22-026622 | 001-41551 | 221465455 | 34 | 10338901 | 1 | 1 | |
| 2022-11-28 | SC 13D | SC 13D | 0001104659-22-122435 | 005-93824 | 221425935 | 34 | 101284 | |||
| 2022-11-28 | SC 13G | SCHEDULE 13G | 0001213900-22-075488 | 005-93824 | 221425281 | 34 | 92919 | |||
| 2022-11-25 | SC 13G | SC 13G | 0001193125-22-292633 | 005-93824 | 221420415 | 34 | 57401 | |||
| 2022-11-21 | 4 | xslF345X03/ownership.xml | 0001213900-22-074313 | 21891 | ||||||
| 2022-11-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-120780 | 21015 | ||||||
| 2022-11-21 | SC 13G | SC 13G | 0001104659-22-120743 | 005-93824 | 221405722 | 34 | 133844 | |||
| 2022-11-21 | 4 | 4 | 0000950170-22-025513 | 7109 | ||||||
| 2022-11-18 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-022492 | 7743 | ||||||
| 2022-11-18 | SC 13G | SC 13G | 0001193125-22-289031 | 005-93824 | 221402343 | 34 | 65243 | |||
| 2022-11-17 | 8-K | 8-K | 3.02,5.03,8.01,9.01 | 0001193125-22-287727 | 001-41551 | 221399089 | 34 | 221958 | ||
| 2022-11-17 | S-8 | S-8 | 0001193125-22-287229 | 333-268426 | 221396845 | 33 | 103740 | |||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057421 | 6131 | ||||||
| 2022-11-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-119645 | 13824 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057405 | 5481 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057401 | 5439 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057400 | 7616 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057399 | 7617 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057398 | 7612 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057397 | 16450 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057395 | 16662 | ||||||
| 2022-11-16 | 424B4 | 424B4 | 0001193125-22-286805 | 333-267911 | 221395560 | 33 | 8577523 | |||
| 2022-11-14 | S-1MEF | S-1MEF | 0001193125-22-285005 | 333-268365 | 221389084 | 33 | 78759 | |||
| 2022-11-14 | 3/A | xslF345X02/ownership.xml | 0001213900-22-072518 | 45408 | ||||||
| 2022-11-14 | FWP | FWP | 0001193125-22-284824 | 333-267911 | 221387864 | 34 | 64579 | |||
| 2022-11-09 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-004721 | 275386 | ||||||
| 2022-11-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-11-09 17:00:00 | 9999999995-22-003246 | 333-267911 | 221374652 | 33 | 1657 | ||
| 2022-11-09 | 3 | xslF345X02/ownership.xml | 0001213900-22-070760 | 58660 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0000899243-22-035474 | 4767 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056309 | 6545 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056308 | 10010 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056307 | 6574 | ||||||
| 2022-11-09 | 3 | OWNERSHIP DOCUMENT | 0001104659-22-116650 | 13474 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056306 | 13151 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056305 | 9255 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056304 | 13156 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056303 | 6545 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056302 | 7971 | ||||||
| 2022-11-08 | CERT | 8A_Cert_ACRV.pdf | 0001354457-22-000634 | 001-41551 | 221367946 | 34 | 217169 | |||
| 2022-11-08 | S-1/A | S-1/A | 0001193125-22-279682 | 333-267911 | 221367230 | 33 | 8647799 | |||
| 2022-11-07 | CORRESP | filename1.htm | 0001193125-22-279086 | 8415 | ||||||
| 2022-11-07 | CORRESP | filename1.htm | 0001193125-22-279075 | 13695 | ||||||
| 2022-11-07 | 8-A12B | 8-A12B | 0001193125-22-279053 | 001-41551 | 221365368 | 34 | 13601 | |||
| 2022-11-03 | S-1/A | S-1/A | 0001193125-22-276311 | 333-267911 | 221356016 | 33 | 9390224 | |||
| 2022-10-17 | CORRESP | filename1.htm | 0001193125-22-263777 | 30398 | ||||||
| 2022-10-17 | S-1 | S-1 | 0000950123-22-010286 | 333-267911 | 221314188 | 33 | 10057529 | |||
| 2022-10-05 | UPLOAD | filename1.pdf | 0000000000-22-010958 | 51138 | ||||||
| 2022-09-22 | DRSLTR | filename1.htm | 0000950123-22-009914 | 79110 | ||||||
| 2022-09-22 | DRS/A | filename1.htm | 0000950123-22-009913 | 377-06317 | 221260133 | 33 | 9219923 | |||
| 2022-09-14 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-004170 | 276254 | ||||||
| 2022-09-12 | UPLOAD | filename1.pdf | 0000000000-22-009877 | 68495 | ||||||
| 2022-08-12 | DRS | filename1.htm | 0000950123-22-008876 | 377-06317 | 221161110 | 33 | 8092327 | |||
| 2021-11-23 | D | xslFormDX01/primary_doc.xml | 06b | 0001781174-21-000002 | 021-422273 | 211438391 | 33 | 10806 | ||
| 2021-02-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001781174-21-000001 | 021-389339 | 21625129 | 33 | 8933 |
One latest value per concept from companyfacts (199 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 42.91M | 2026-11-10 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 20.40M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 635.01 | 2026-11-13 | S-3 | 2026-11-16 | 0001193125-26-463828 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 635.01 | 2026-11-13 | S-3 | 2026-11-16 | 0001193125-26-463828 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 300.00M | 2026-11-13 | S-3 | 2026-11-16 | 0001193125-26-463828 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-13 | S-3 | 2026-11-16 | 0001193125-26-463828 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-13 | S-3 | 2026-11-16 | 0001193125-26-463828 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 616,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -54,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 4.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 12.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 513,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 4.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -26,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 400.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 6.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | Assets | Assets | USD | 85.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 79.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 111,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 26,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 30.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 133,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-12-15 | 0000950170-22-026622 |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 30.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 91.44M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-125929 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 47.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 76.80M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-12-15 | 0000950170-22-026622 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 47.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 47.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 6.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001193125-26-221634 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 5.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 42.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 42.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 42,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -55.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 122.52M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 11.14M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 91.53M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-125929 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 30.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 1.54M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-12-15 | 0000950170-22-026622 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 500,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 78.32M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 16.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 42.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 13.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 77.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 1.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 408,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046056 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | Depreciation | Depreciation | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.209 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.06 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046056 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 2.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.026 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.035 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 13.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -78.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -77.83M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 189,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 16.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -16.34M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 25,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 769,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -16,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.69M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -905,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -234,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -534,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 7.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 1.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 404,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 404,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 404,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046056 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 404,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 404,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 300,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 109,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | Liabilities | Liabilities | USD | 14.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 85.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 14.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 5.09M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 7.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 46.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -47.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -54.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 2.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 57.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -57.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 1.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 693,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 1.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.082 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 245,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 945,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -137,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | -27.00M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041593 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -412,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 26.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 101,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 1.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 99.81M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 7.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 70.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 12.47M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 60.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 73.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -54.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 8.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 43.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 196,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 196,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | RestrictedStockValueSharesIssuedNetOfTaxWithholdings | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | USD | -34,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -329.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 56,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | -2.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 6.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 935,963 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.016 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 1.005 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.029 | 2022-07-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061553 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.049 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.036 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 630,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 342,077 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 344,368 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001193125-26-221634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 4.33 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001193125-26-221634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 651,411 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.07 | 2022-07-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061553 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 8.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 4.46 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 3.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 6.17 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 8.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 4.46 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 8.94 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 3.97 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.57 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 30.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 131,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 70.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.406 | 2022-11-17 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 8,110 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 349,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 2.00M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 8,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 134,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046056 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 122.52M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 122.85M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 27.47M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 27.47M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 27.47M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010331 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -100,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037618 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046056 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 20.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 608,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115123 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 41.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 41.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463419 |